Surrogate Marker For Tropism-A Multi-Center, Open Label, Pilot Study.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Maraviroc (Primary)
- Indications HIV infections
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Pfizer
- 18 Nov 2010 Additional lead trial centre (ViiV Healthcare) identified as reported by ClinicalTrials.gov.
- 10 Jul 2008 Actual end date (22 Apr 08) added from ClinicalTrials.gov.
- 10 Jul 2008 Status changed from recruiting to discontinued, reported by ClinicalTrials.gov.